Regenerative Medicine in Eye Care
Emerging Therapeutics and Clinical Applications.
Course Overview
Regenerative medicine represents one of the most rapidly evolving frontiers in eye care. From autologous serum tears and platelet-rich plasma to amniotic membrane therapies and emerging cellular approaches, these modalities offer new possibilities for patients with conditions that have historically been difficult to treat. This Masterclass provides a rigorous, clinically grounded exploration of regenerative therapeutics — their scientific foundations, current evidence, and practical applications in optometric and collaborative care.
Clinical Relevance
Patients with severe ocular surface disease, neurotrophic keratopathy, and other refractory conditions increasingly present to optometrists having exhausted conventional therapies. Understanding regenerative options — what they are, how they work, and when to consider them — enables clinicians to provide more complete care and to participate meaningfully in collaborative management of complex cases.
Course Details
Credit hours and COPE approval pending. Join the waitlist to receive notification when this course becomes available.
Learning Objectives
Upon successful completion of this educational experience, the clinician will be able to:
Explain the scientific principles underlying regenerative therapeutic approaches in eye care.
Describe the clinical evidence supporting autologous serum tears, platelet-rich plasma, and amniotic membrane therapies.
Identify appropriate candidates for regenerative therapeutic approaches based on clinical presentation and prior treatment history.
Recognize the role of emerging cellular and biologic therapies in the evolving landscape of ocular surface disease management.
Apply a collaborative care framework for patients requiring regenerative therapeutic approaches.
Course Modules
This educational experience is organized into the following modules. Content is subject to refinement prior to final release.
Foundations of Regenerative Medicine
Growth factors, cellular signaling, and the biological principles that underlie regenerative therapeutic approaches.
Autologous Serum Tears
Preparation, composition, clinical evidence, and patient selection — the most established regenerative option in ocular surface disease.
Platelet-Rich Plasma
The science of PRP, its ocular surface applications, and the current state of the evidence.
Amniotic Membrane Therapies
Cryopreserved and dehydrated amniotic membrane — mechanisms, clinical applications, and the evidence base for their use in ocular surface disease.
Emerging Approaches
Stem cell therapies, exosome-based treatments, and the horizon of regenerative eye care — what is coming and what clinicians should know.
Clinical Integration
Patient selection, collaborative care pathways, and the practical considerations for incorporating regenerative approaches into clinical practice.
Educational Philosophy
This educational experience is designed to support clinical reasoning and evidence-informed decision-making. It does not constitute clinical advice and should not replace consultation of official prescribing information, applicable standards of care, or the clinical judgment of the treating clinician. COPE approval and credit hours are pending and will be confirmed prior to release.
Be the First to Know
Join the waitlist for Regenerative Medicine in Eye Care and receive notification when this educational experience becomes available.
Companion Resource
The Clinician's Companion
Explore the therapeutic reference library designed to support the clinical reasoning developed in MYODCE educational experiences.
Explore the Companion